Drugs / Hypertonic Saline Solution
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06267118 Comparator | Nov 2023 → Nov 2024 overdue | respiratory syncytial virus bronchiolitis | Combined Military Hospital, Pakistan | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hypertonic Saline Solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06267118 ↗ |
| Route | Inhaled | “will be nebulized with hypertonic saline every 6 hours” NCT06267118 ↗ |